Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPOPNEUMO: Fractionated Pneumococcal Vaccine Strategies
NCT02279589Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2014
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of Pneumo 23 in pneumococcal infection, sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2014; status: completed.
02
Drugs
Pneumo 23
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02279589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279589.